Post-Essential Thrombocythemia (ET) MF
1 clinical trials · Condition
◉ Watch Post-Essential Thrombocythemia (ET) MF
| Record | Firm | Date |
|---|---|---|
| Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF (NCT01392443) | Novartis Pharmaceuticals | 2010-10-14 |
Track Post-Essential Thrombocythemia (ET) MF automatically
Every clearance here is in the API, with alerts when new ones post.